You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Maintenance treatment with antipsychotic drugs for schizophrenia
|
---|---|
Published in |
Cochrane database of systematic reviews, May 2012
|
DOI | 10.1002/14651858.cd008016.pub2 |
Pubmed ID | |
Authors |
Stefan Leucht, Magdolna Tardy, Katja Komossa, Stephan Heres, Werner Kissling, John M Davis |
Abstract |
The symptoms and signs of schizophrenia have been firmly linked to high levels of dopamine in specific areas of the brain (limbic system). Antipsychotic drugs block the transmission of dopamine in the brain and reduce the acute symptoms of the disorder. This review examined whether antipsychotic drugs are also effective for relapse prevention. |
X Demographics
The data shown below were collected from the profiles of 35 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 8 | 23% |
Spain | 4 | 11% |
Finland | 1 | 3% |
India | 1 | 3% |
United States | 1 | 3% |
Mexico | 1 | 3% |
United Kingdom | 1 | 3% |
Unknown | 18 | 51% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 32 | 91% |
Practitioners (doctors, other healthcare professionals) | 2 | 6% |
Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 275 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | <1% |
Netherlands | 1 | <1% |
Colombia | 1 | <1% |
Denmark | 1 | <1% |
Hong Kong | 1 | <1% |
Unknown | 269 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 37 | 13% |
Researcher | 36 | 13% |
Student > Ph. D. Student | 35 | 13% |
Student > Master | 33 | 12% |
Other | 27 | 10% |
Other | 50 | 18% |
Unknown | 57 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 105 | 38% |
Psychology | 39 | 14% |
Neuroscience | 12 | 4% |
Nursing and Health Professions | 12 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 10 | 4% |
Other | 29 | 11% |
Unknown | 68 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 76. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 May 2023.
All research outputs
#568,675
of 25,621,213 outputs
Outputs from Cochrane database of systematic reviews
#1,010
of 13,152 outputs
Outputs of similar age
#2,645
of 176,872 outputs
Outputs of similar age from Cochrane database of systematic reviews
#10
of 192 outputs
Altmetric has tracked 25,621,213 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,152 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,872 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 192 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.